Pneumocystis jirovecii pneumonia epidemiology and demographics

Pneumonia Main Page
Pneumocystis jirovecii pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pneumocystis jirovecii pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pneumocystis jirovecii pneumonia epidemiology and demographics On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pneumocystis jirovecii pneumonia epidemiology and demographics
CDC on Pneumocystis jirovecii pneumonia epidemiology and demographics
Pneumocystis jirovecii pneumonia epidemiology and demographics in the news
Blogs on Pneumocystis jirovecii pneumonia epidemiology and demographics
Pneumocystis jirovecii pneumonia
Risk calculators and risk factors for Pneumocystis jirovecii pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pneumocystis jirovecii pneumonia exists worldwide, in humans and animals. Serologic evidence indicates that most healthy children have been exposed by age 3 to 4. Pneumocystis pneumonia (PCP) occurs in immunosuppressed individuals and in premature, malnourished infants.